Technology News and Research

RSS

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with 177Lu-PSMA radionuclide therapy.

5 Sep 2023

How is next-generation protein sequencing democratizing protein sequencing?

In this interview, NewsMedical speaks with Jeff Hawkins, CEO of Quantum-Si, about the challenges of conventional proteomic methods, as well as how next-generation protein sequencing is democratizing protein sequencing.

From Quantum-SI 5 Sep 2023

Sex hormones drive differences in male and female mouse kidneys

Female kidneys are known to be more resilient to disease and injury, but males need not despair. A new USC Stem Cell-led study published in Developmental Cell describes not only how sex hormones drive differences in male and female mouse kidneys, but also how lowering testosterone can "feminize" this organ and improve its resilience.

5 Sep 2023

New tool can diagnose autism in children as young as 16 months

Results of clinical studies published simultaneously today in the Journal of the American Medical Association (JAMA) and in JAMA Network Open demonstrate that measuring children's looking behavior predicts expert clinical diagnosis of autism in children between ages 16 to 30 months tested with a high degree of accuracy.

5 Sep 2023

IKIDS study receives new funding to explore how environmental exposures influence child health

Seven years after an initial $17.9 million award from the National Institutes of Health, the Illinois Kids Development Study at the University of Illinois Urbana-Champaign will receive approximately $13.7 million – awarded in two phases – to continue its work for another seven years.

5 Sep 2023

Illumina's board appoints Jacob Thaysen, Ph.D. as its new Chief Executive Officer

llumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., as Chief Executive Officer, effective September 25, 2023.

From Illumina, Inc. 5 Sep 2023

UK government invests £5.5 million in Medicines Manufacturing Skills Centre of Excellence

The government is helping to sustain and grow the 280,000-strong UK life sciences workforce by today (Tuesday 5 September) announcing £5.5 million to establish a Medicines Manufacturing Skills Centre of Excellence.

5 Sep 2023

Study characterizes SARS-CoV-2 subvariants to inform development of next-generation COVID-19 vaccines

Researchers characterized two novel SARS-CoV-2 XBB variants, EG.5.1 and XBB.2.3.

4 Sep 2023

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division.

4 Sep 2023

ChatGPT can debunk vaccine myths and increase vaccine uptake, study finds

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics.

4 Sep 2023

AI-driven analysis of MRI scans could pave the way for improved multiple sclerosis treatment

New research exploring cutting-edge Artificial Intelligence (AI) technology to better analyse MRI scans of patients with multiple sclerosis (MS) could unlock crucial insights into disease progression and pave the way for improved treatment of people living with the condition.

4 Sep 2023

New breakthroughs by NPL scientists could transform cancer treatment

New breakthroughs by scientists at the National Physical Laboratory (NPL) are set to transform cancer treatment in the UK and worldwide.

4 Sep 2023

Innovate UK funding to support the development of powdered gene therapy for bone graft augmentation

TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency.

4 Sep 2023

Digital tech could unlock warning signs for imminent sudden cardiac arrest

A new study in Lancet Digital Health identifies early warning symptoms like chest pain and dyspnea that are moderately associated with imminent sudden cardiac arrest. The research suggests that future digital technologies could combine these symptoms with biometric data to more precisely predict and potentially prevent these life-threatening events.

3 Sep 2023

Scientists convert former barn into cutting-edge animal behavior lab

Researchers from the Cluster of Excellence Centre for the Advanced Study of Collective Behaviour (CASCB) and the Max Planck Institute of Animal Behavior have converted a former barn into a cutting-edge technology lab for complex behavioral analysis

1 Sep 2023

Study sheds light on immune cells' ability to collectively migrate through complex environments

When fighting disease, our immune cells need to reach their target quickly. Researchers at the Institute of Science and Technology Austria (ISTA) now discovered that immune cells actively generate their own guidance system to navigate through complex environments.

1 Sep 2023

Exposures to biological sources linked to increased risk of chemical intolerance

What initiates chemical intolerance (CI)? In a newly released survey of thousands of U.S. adults, respondents most frequently cited exposures to biological sources, such as mold and algae "blooms," and/or fossil fuels, their combustion products and synthetic chemical derivatives such as pesticides, plastics and persistent organic pollutants.

1 Sep 2023

Integrating HIV and addiction treatment improves outcomes for people who inject drugs in Russia

New research from Boston Medical Center found that providing pragmatic support, specifically rapid access to antiretroviral therapy, pharmacotherapy for opioid use disorder, and strengths-based case management, improved treatment outcomes for people with HIV who inject drugs in St. Petersburg, Russia.

1 Sep 2023

Weighted lottery helps ensure equitable allocation of scarce COVID-19 medication

A program designed to ensure fairness and that people living in the most disadvantaged U.S. neighborhoods would be offered a scarce, potentially life-saving medication proved feasible in a large health system.

1 Sep 2023

TherageniX and University of Nottingham awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration

Funding from Innovate UK’s Transforming Medicines Manufacturing program supporting innovative technologies for intracellular drug delivery.

1 Sep 2023

Technology News and Research

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

How is next-generation protein sequencing democratizing protein sequencing?

Sex hormones drive differences in male and female mouse kidneys

New tool can diagnose autism in children as young as 16 months

IKIDS study receives new funding to explore how environmental exposures influence child health

Illumina's board appoints Jacob Thaysen, Ph.D. as its new Chief Executive Officer

UK government invests £5.5 million in Medicines Manufacturing Skills Centre of Excellence

Study characterizes SARS-CoV-2 subvariants to inform development of next-generation COVID-19 vaccines

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

ChatGPT can debunk vaccine myths and increase vaccine uptake, study finds

AI-driven analysis of MRI scans could pave the way for improved multiple sclerosis treatment

New breakthroughs by NPL scientists could transform cancer treatment

Innovate UK funding to support the development of powdered gene therapy for bone graft augmentation

Digital tech could unlock warning signs for imminent sudden cardiac arrest

Scientists convert former barn into cutting-edge animal behavior lab

Study sheds light on immune cells' ability to collectively migrate through complex environments

Exposures to biological sources linked to increased risk of chemical intolerance

Integrating HIV and addiction treatment improves outcomes for people who inject drugs in Russia

Weighted lottery helps ensure equitable allocation of scarce COVID-19 medication

TherageniX and University of Nottingham awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News